Seminars in Oncology
Volume 30, Issue 5 , Pages 689-697, October 2003

The development of differentiation agents for the treatment of prostate cancer

  • Matt Galsky

      Affiliations

    • Department of Medicine, Joan and Sanford I. Weill Medical College of Cornell University, New York, NY, USA
    • ,
  • W.Kevin Kelly

      Affiliations

    • Genitourinary Oncology Service, Division of Solid Tumor, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • Corresponding Author InformationAddress reprint requests to W. Kevin Kelly, DO, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(03)00355-5

doi:10.1016/S0093-7754(03)00355-5

Seminars in Oncology
Volume 30, Issue 5 , Pages 689-697, October 2003

Article Tools

* Image Usage & Resolution